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Summary 
Signaling through surface CD40 is essential for selecting B cells that have mutated their immu- 
noglobulin variable region genes in germinal centers and is an important signal in the early stages 
of antibody responses to T  cell-dependent antigens. It is shown that a subset of CD45RO +, 
CD4 + T cells isolated from human tonsil contains preformed 30-35-kD ligand for CD40. This 
is expressed on their surfaces within 5 min of their antigen-receptor complexes interacting with 
CD3e antibodies bound to ox erythrocytes. This surface expression does not require de novo 
protein synthesis and lasts for only 1-2 h. Preformed CD40 ligand (CD40L) was not detected 
in any CD4 + CD45RA + T  ceUs, but >90%  of all CD4 + T  cells from the tonsil can be in- 
duced to express large amounts of CD40L on culture with phorbol myristate acetate and the 
calcium ionophore ionomycin. This expression of CD40L  starts between 1 and 2 h, peaks at 
6 h,  and remains at a high level for >20 h.  It is totally prevented by adding a concentration 
of cycloheximide that inhibits CD25 synthesis by these activated cells. While CD3e antibody 
bound to ox red cells is a good inducer of surface expression of CD40L, it is a much less potent 
inducer of CD40L synthesis than phorbol myristate acetate with ionomycin. Immunohistolog- 
ical analysis of tonsil sections shows that cells containing CD40L are located mainly in the outer 
zone of germinal centers and the margins of the T  zones that are rich in dendritic cells (inter- 
digitating cells). The distribution of these calls is consistent with: (a) their interaction in T zones 
with B cells that have taken up and processed antigen and (b) their involvement in B cell selection 
in germinal centers. 
G 
erminal centers are  a  site of rapid  and extensive ex- 
pansion of B cell clones activated during responses to 
protein-based Ag (1, 2).  The members of these clones un- 
dergo somatic mutation in their Ig V region genes (3) and 
appear  to  be  selected subsequently on  the basis  of their 
specificity for Ag held on local follicular dendritic cells (4). 
Selected cells leave the germinal center either as memory B 
cells (5), or plasmablasts (6). Tonsil germinal center B cells, 
isolated and cultured in standard tissue culture medium, un- 
dergo death by apoptosis within a few hours, but this can 
be delayed if their surface Ig is cross-linked and further pro- 
tection from apoptosis is achieved on exposure to the 30-35- 
kD CD40 ligand (CD40L) 1 (4, 7). CD40L can be expressed 
on the surface of T cells during cognate interaction with B 
cells or dendritic cells (8-10). This opens the possibility that 
1  Abbreviation used in this paper: CD40L,  CD40 ligand. 
the germinal center B cells, centrocytes, pick up native Ag 
held on follicular dendritic cells, process it,  and present it 
to local T cells that are then induced to express CD40L (11). 
It has been reported that centrocytes can take up Ag from 
follicular dendritic cells, process it, and present it to T cells 
(12). Experiments in which CD40L interaction with CD40 
is blocked in established germinal centers in mice indicate 
that CD40 is required for memory B cell formation (13). 
Both B cells and dendritic cells in the T zones of secondary 
lymphoid organs constitutively express CD40 (14). This opens 
the possibility that T cell priming and extrafollicular T ceU-B 
cell interactions involve signaling through CD40 and CD40L. 
Inhibition of this signaling pathway in mice using Ab against 
CD40L markedly impairs primary T cell-dependent Ab re- 
sponses (15), as well as germinal center formation (16). An 
immunohistological analysis of human secondary lymphoid 
tissues, using a mAb against human CD40L, identified CD40L 
in germinal centers (17), but studies in mice have reported 
CD40L expression in T  zones, but not in germinal centers 
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and the induction  of its expression by human tonsil T  cells. 
It  indicates  that  CD40L  is  present  inside  a  minority  of 
CD45RO + ,  CD4 +  T  cells,  in  the T  zones  and  is present 
in  many  germinal  center  T  cells.  T  cells  with  preformed 
CD40L can be induced  to express this rapidly on their sur- 
faces by signaling  through  their  TCK complexes. 
Materials  and Methods 
Tonsils and the Preparation of Tonsil Cell Suspensions.  Human 
tonsils were obtained from patients undergoing tonsillectomy to 
relieve obstruction to the respiratory passages and improve drainage 
of the middle ear. The age of these patients ranged from 5 to 27 
yr. All of the tonsils  studied were histologically normal. Pairs of 
tonsils were carefully teased,  the mononuclear cell suspension was 
layered onto Ficoll-Isopaque (Pharmacia, Milton Keynes,  United 
Kingdom) and centrifuged at 450 g for 20 min at 20~  and the 
interface cells were washed in RPMI 1640 (GIBCO, Paisley, United 
Kingdom). 
Antibodies andFluorochwmes.  The following mAbs, after coating 
on ox RBC, were used for negative selection procedures or to acti- 
vate T cells: BU12, CD19 (14); GC6, CD45RA (The Binding Site, 
Birmingham, United Kingdom); B941,  CD8 (a gift from Claud 
Mawas,  Marseille,  France) (18); UCHT1, CD3 (a gift from Peter 
Beverley, University College Hospital, London) (18). These anti- 
bodies were attached to ox RBC, using the chromic chloride tech- 
nique (19). The coatings involved suspending 2  x  109 ox RBC 
in  100 gl saline  containing 0.3 mg of IgG preparation of mAb. 
To this, 60/zg of aged CrCh was added in 600/~1 saline. The mix- 
ture was then incubated overnight at 4~  before washing the cells 
and resuspending them in RPMI 1640.  Fresh cell coatings were 
made for each experiment. When >2  x  109 ox RBC were used, 
replicate batches of coated cells were prepared. 
The following conjugated mAbs were used for FACScan  |  (Becton 
Dickinson, Oxford, United Kingdom) analysis, CD3-PE and CD57- 
FITC (Becton Dickinson),  CD45KA-PE  (Serotec  Ltd.,  Oxford, 
United  Kingdom),  CD19-FITC,  CD4-FITC,  CDS-PE,  CD25- 
FITC, CD45RO-PE (Dako, High Wycombe, United Kingdom). 
The five different mAbs against CD40L used were: 5c8 (a gift from 
Seth Lederman, Columbia University, New York) (10), 5B4 (anti- 
TRAP1) (a gift from Richard Kroczek, Robert Koch Institute, 
Berlin)  (9),  Mg0, M91,  and M92 (gifts from Richard Armitage, 
Immunex, Seattle).  Recombinant CD40L (20) was also a gift from 
Richard Armitage. Recombinant human CD40 linked to human 
Fc# heavy chain was a kind gift from Dr. Peter Lane of the Basel 
Institute of Immunology (21). Both 5B4 and Mg0 were biotinylated, 
and GC6 was labeled with FITC, as described in (22).  The fol- 
lowing fluorescent detection reagents were used:  streptavidin-PE 
(Becton Dickinson), sheep anti-mouse IgG-FITC (Sigma Chem- 
ical Co., Poole, United Kingdom). For immunohistology, in addi- 
tion to the five anti-CD40L mAbs, mAbs against the following 
specificities were used: Ki67 (23), mAb MIB1 (a gift from Johannes 
Gerdes, Borstal, Germany): CD45RO, mAb UCHL1 (a gift from 
Peter Beverley) (24), and CD4, mAb MT310 (Dako). Rabbit anti- 
mouse Ig and alkaline phosphatase mouse anti-alkahne phospha- 
tase complex (Dako) were used to detect the binding of these Abs. 
Cell Fractionation and Phenot~ic  Analysis of Isolated Cells.  The 
tonsil cell  suspension was submitted to negative selection using 
a direct rosetting technique with mAb-coated ox RBC. To isolate 
CD4 § T cells, ox RBC coated with CD19 and CD8 mAbs were 
used. Ox RBC coated with mAbs against CD45KA and CD8 were 
used to isolate CD4 §  CD45RO § T cells. The procedure was set 
up to obtain high cell purity,  rather than high yields.  Between 
5  x  105 and 109 tonsil cells were incubated with 2  x  109 ox RBC 
coated with CD19 mAb for 20 rain, then centrifuged onto Ficoll- 
Isopaque for 20 min before the nonrosetting cells were harvested 
from the interface.  These cells were then either incubated with 
4  x  105 ox RBC cells coated with CD19 mAb and 4  x  10  s ox 
RBC cells coated with  CD8  mAb to isolate CD4 § T  cells,  or 
with the same numbers of CD45RA and CD8 mAb-coated ox 
RBC to isolate CD4 § CD45RA l~  T  cells.  Again,  the non- 
rosetting cells were separated by density centrifugation. The cells 
separated  with  CD19  and  CD8  mAb-coated  RBC  to  isolate 
CD4 § T cells were subjected to two rounds of rosetting, and the 
final cell yields were between  1.3 and  1.8  x  107. More efficient 
separations  were obtained with negative selection using CD8 and 
CD45RA mAb-coated RBC for which only one round of roset- 
ting was required, and the final cell yields were between 1.9 and 
3.0  x  107. After the rosetting procedure and gradient centrifu- 
gation, the interface cells were washed and resuspended in RPMI 
1640 supplemented with 10% FBS (GIBCO). All the procedures 
were performed at 4~  except centrifugation of cells using Ficoll- 
Isopaque, which was carried out at 20~  The purity of the different 
isolated T  cell subsets was assessed by FACScan |  analysis  as de- 
scribed below. 
Culture Conditions. Freshly isolated T cells were incubated in 96 
flat-bottom-well plates at a concentration of 5  x  105 cells/ml.  The 
cells were cultured with two different conditions:  with PMA at 
I nM (Sigma Chemical Co.) and ionomycin 0.7/zg/ml (Calbiochem- 
Novabiochem, Beeston, United Kingdom), or with CD3e mAb- 
coated ox RBC.  These latter ox RBC were added at a ratio of 
10 red cells per lymphocyte (having been determined as the ratio 
that gave optimal expression of CD40L). Cycloheximide (Sigma 
Chemical Co.) was used to study de novo protein synthesis. The 
dose used (10 gg/ml) was identified as the minimum dose needed 
to produce >95% inhibition of CD25 expression by T  cells acti- 
vated by PMA with ionomycin. Cells were preincubated with cy- 
cloheximide for 2 h before adding PMA with ionomycin or CD3e 
mAb-coated ox RBC, and it was maintained in the cell cultures 
during the total culture time. 
Phenotypic Analysis.  Cell suspensions were stained by direct or 
indirect immunofluorescence  by washing them in PBS supplemented 
with 5% goat serum (GIBCO), after which 2  x  105 cells were 
incubated with the appropriate dilution of the first Ab (2 Abs for 
double immunofluorescence staining) for 30 min on ice. After two 
washes the cells labeled with direct conjugates were fixed with 1% 
formaldehyde (Sigma Chemical Co.). Cells labeled with biotinylated 
5B4 or M90 mAb were incubated with streptavidin-PE, and cells 
labeled with 5c8 were incubated with sheep anti-mouse IgG FITC 
for a further 30 rain before washing and fixing. Cells were ana- 
lyzed within 48 h of staining using a FACScan |  analyzer (Becton 
Dickinson). 
Immunohistology.  4-gm acetone-fixed serial cryostat sections  of 
tonsils were stained to reveal CD40L  expression.  The immuno- 
alkaline phosphatase technique was used, as described in reference 
25. Briefly, the sections were incubated with the optimal dilutions 
of Ab for 1 h in a moist chamber, and were then thoroughly washed 
before a rabbit anti-mouse Ig was added for 45 min. After further 
washing, an alkaline phosphatase-conjugated mouse anti-alkaline 
phosphatase complex was added for 30 min. To increase the sensi- 
tivity of the technique,  these two last steps were repeated twice, 
and,  finally,  the  bound  alkaline  phosphatase  was developed by 
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BB salt (Sigma Chemical Co.). Endogenous alkaline phosphatase 
activity was blocked with levamisole. 
Quantitation of the number of T cells with a particular pheno- 
type per unit area was carried out using the point counting tech- 
nique of Weible (26). Slides carrying 4-/~m sections were viewed 
at a magnification of 250 with a 1-cm square graticule divided into 
11 vertical and 11 horizontal lines, each 10-mm from the other, 
located in one eyepiece. The area of the section was estimated by 
the number of line intercepts that fell on the area being assessed, 
and the number of cells in that area were counted. An intercept 
will fall, on average, onto each 0.4 mm  2 of section. The frequency 
of cells in a particular compartment is expressed  as the average 
number of cells per square millimeter of that compartment. The 
following compartments were identified: (a) the T zone that was 
taken to be that area outside follicles that contained confluent or 
near confluent CD4 +  T  cells;  (b)  the  light  zone of germinal 
centers that was identified as the area within germinal centers that 
did not contain confluent Ki67 + B cells (27);  (c) the outer zone 
that is defined in this study as a band of CD4 + T  cells located 
as a layer at the outer edge of the light zone. 
Results 
Induction of CD40L Expression on the Surfaces of CD4 + T 
Cells.  Previous studies have shown that the phenotype of al- 
most all T  cells found in tonsil germinal centers are CD4 + 
CD45RO +  and  fail  to  express  Bcl-2,  a  minority  express 
CD57 (28, 29). Initial experiments studied all CD4 + T  cells 
that were prepared by negative selection of tonsil cell suspen- 
sions, CD8 + and CD19 + cells being removed. The pheno- 
type of these negatively selected cells in a representative ex- 
periment is shown in Fig.  1. The mean level of CD8 + cell 
contamination  _+  SD in 10 experiments was 0.51  _+  0.6%, 
and CD19 + cell contamination was 5.0  _+  5.3. Most CD4 + 
tonsil  T  ceils  were  found  to  express  CD45RA  without 
CD45RO,  or CD45RO without CD45RA.  Unlike human 
peripheral blood T  cells, relatively few tonsil CD4 + T  cells 
were found to express both these CD45 isoforms. The propor- 
tion of CD4 + CD57 + tonsil cells expressing CD45RO was 
assessed in four experiments. Again, CD8 + and CD19 + cells 
were removed by negative selection. In the four experiments, 
99.2,  98.3,  99.8,  and  99.9%  of  the  CD57 +  cells  were 
CD45RO high. Very few of these cells coexpress CD45tLA 
(Fig.  1). 
None of the CD8-  CD19-  tonsil T  cells isolated were 
found to express CD40L on their surfaces constitutively, but, 
on culture in I nM PMA plus 0.7/zg/ml ionomycin, a small 
proportion of cells started to express low levels of this pro- 
tein on their surfaces within 15 rain (Fig. 2). All of the cells 
expressing CD40L at this time were CD45RA 1~  This 
level of expression remained constant for 1 h, but between 
1 and 2 h most CD4 § cells, including CD45RA + cells,  had 
started to express CD40L.  After 2 h, there was a rapid in- 
crease in the level of surface CD40L expression, peaking at 
6 h when levels were 10-20 times those seen at 15 min (Fig. 
2). Double staining for CD57 (Fig. 1) shows that a median 
of 5% (range 4-11%) of the CD4 + tonsil T  cell fraction ex- 
pressed CD57.  Most of these cells were induced to express 
surface CD40L within 15 min of activation with PMA plus 
ionomycin. All of the CD57 + cells expressed CD40L after 
20 h culture with PMA plus ionomycin. During these time 
course experiments, there was no significant alteration in the 
relative proportions of CD45RA h~h cells and CD45RA l~ 
cells (Fig. 2). In five experiments, in which the starting pro- 
portion  of CD45RA ]~  cells was  63,  67,  50,  37,  and 
45%,  after 20 h culture with PMA and ionomycin, the re- 
spective alteration in the percentage of CD45RA l~  cells 
was  +3,  -10,  +18,  +2,  and  -2%. 
Evidence  that  CD40L  Is  Contained  Witfiin  a  Subset of 
CD4 +,  CD45RA ~/-"  T  Cells. To assess  the requirement 
for de novo synthesis of CD40L for its surface expression, 
the experiments described in the previous paragraph  were 
repeated in the presence or absence of 10 #g/ml cyclohexi- 
mide. This was shown to be the minimum concentration of 
this agent that caused >95%  inhibition of new CD25  ex- 
pression by tonsil T cells cultured with PMA plus ionomycin. 
The cyclohexirnide was added 2 h before the addition of PMA 
and ionomycin and was present throughout the culture. Fig. 
3 shows that the expression of CD40L induced by PMA and 
ionomycin on CD45RA l~  tonsil T  ceils at 15 min is not 
inhibited by the presence of cycloheximide. The second phase 
of CD40L expression by CD45RO + cells, starting 1 h after 
the addition of PMA plus ionomycin (Fig. 3 A),  is totally 
inhibited in the presence of cydoheximide (Fig. 3 B).  The 
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Figure 1.  The phenotype of CD8-,  CD19-  T  cells isolated from 
human tonsil. The results are shown as FACScan  |  dot plots of  the isolated 
T cells. The percentage of cells in the appropriate quadrants of the dot 
plots shown are: CD3 +  , CD19- 90%; CD4 +  , CDS- 92%; CD45RO +  , 
CD45RA-  48%;  CD45RA+,  CD45RO-  44%;  and  CD57+, 
CD45RA- 7%. Fluorescence  intensity is plotted on a log scale. The cells 
shown on these dot plots are those contained within the gate containing 
viable small and large lymphocytes, as assessed by forward and 90  ~ light 
scatter. 
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Figure 2.  Induction  of  surface  CD40L  expression  on T cells  at intervals  after  activation  with PMA and ionomycin.  Cells  were  stained with a CD45RA-FITC 
mAb and a biotinylated  CD40L mAb, which was revealed  with stmptavidin-PE. A subset of CD45RA - T cells express low levels of CD40L by 15 
min. This level of CD40L expression  by a subset of CD45RA -  T cells remains relatively  constant during the first hour of culture. By 2 h, most 
cells in both the CD45RA- and the CD45RA+ T celt subsets express some surface  CD40L. The level of surface CD41)L expression  increases to reach 
its maximum by 6 h. 
expression of CD40L by CD45RAhig  h cells,  starting only 
i  h  after the addition of PMA and ionomycin (Fig.  3 A), 
is  also  totally inhibited  in  the  presence of cycloheximide 
(Fig. 3 B). These experiments were analyzed using TRAP1, 
5c8, and M90 mAbs against CD40L. Each Ab gave com- 
parable results.  The CD40L  expression detected by these 
antibodies was totally blocked in the presence of excess re- 
combinant CD40L. 
Activation Of CD45RA-CD8-  Tonsil T Cells through their 
T  Cell Receptor Complexes Induces the Surface Expression of 
Preformed CD40L  but  Relatively  Little  New  Synthesis of 
CD4OL.  In  further experiments,  CD8-  CD45RA-  cells 
were cultured with PMA plus ionomycin or ox RBC coated 
with mAb against CD3e. Early expression of surface CD40L 
was also induced by interaction with CD3e-coated ox RBC. 
This was not altered by the presence of 10/~g/ml cyclohexi- 
mide (Table 1). When the cells were stimulated through CD3e, 
the second cycloheximide-sensitive phase of CD40L expres- 
sion was considerably less marked than it was when cells were 
activated using PMA with ionomycin. Far fewer cells were 
induced to express CD40L, and the duration of expression 
was much shorter. A  further set of three experiments was 
carried out to assess the rate of early expression of surface 
CD40L.  Both PMA with ionomycin and ox RBC coated 
with mAb against CD3e induced surface CD40L within 5 
min of adding these activators. The mean  _+  SD levels of 
surface CD40L expressed after 5 and 15 rain were: 47.5  _+ 
9.4, and 51.3 _  10.2 for activation using PMA with ionomycin 
and 16.8 +_  3.3, and 16.4 +_ 8.5 for cultures where ox RBC 
coated with mAb against  CD3e were added￿9 
Location of Cells Containing CD40L in Tonsil  Sections. Serial 
frozen sections from each of three tonsils were studied for 
the expression of CD40L, CD45RO, and CD4 by tonsil T 
cells. The dark zone of the germinal centers was identified 
by staining for the proliferation-associated nuclear Ag Ki67. 
The average frequency of CD4 + cells, CD45RO + cells, and 
CD40L + cells in the apical  plus basal  light zones and the 
outer light zone of germinal centers, and in the T  zones in 
three tonsils is shown in Table 2. Fig. 4, a-d are photomicro- 
graphs of four serial tonsil sections, showing a secondary fol- 
lide and an area of T zone stained respectively, for CD40L, 
Ki67, CD45RO, and CD4 expression. The outlines of the 
zones are shown in Fig. 4 e. Fig. 4fis a high magnification 
photomicrograph showing the granular nature of the CD40L 
staining. Cells with CD40L are seen both inside and outside 
germinal centers, but are most frequent in the outer zone 
of germinal centers. This zone also contains more CD45RO 
cells per unit  area  than  the T  zones.  CD40L + cells  were 
much less frequent in the rest of the light zone. Cells with 
CD40L appeared to be more frequent at the edge than in 
the heart of T  zones (Fig. 4 a). As expected, the frequency 
in germinal centers of CD4 + and CD45RO + cells counted 
in serial sections was the same, confirming that these mole- 
cules  are  coexpressed on germinal center T  cells.  Similar 
CD40L staining was obtained with the 3 mAbs: 5c8, M90, 
and M91. The mAb M90 gave the strongest staining. When 
excess soluble human CD40 linked to human Fcp (21) was 
mixed with the 5c8, M90,  or M91  added to the sections, 
staining  was  blocked.  It  has  previously been reported by 
Lederman et al. (17) that the 5c8 does not bind to the CD40L 
that has already engaged CD40. Comparative blocking ex- 
periments were carried out indicating that soluble CD40 also 
1296  Preformed  CD40 Ligand in a Subset of Memory T Cells A 
76 
6O 
~,  0  ,  , 
0  1  2  3  4  S  6 
hours from adding PIIA  and ionomyoln 
100 
B 
75 
60 
0  ,  ,  ,  T  ,  ,  ,  , 
0  1  2  $  4  w  8 
hours after adding PMA and Ionomyoln 
Figure 3.  The  surface CD40L expression by  the 
CD45KA- and the CD45KA  + T cell subsets induced by 
PMA and ionomyein,  and the dependence  of this effect  of 
activation on protein synthesis. The mean _+ SD expression 
of surface CD40L by CD45KA  § cells (i) and CD45RO+ 
cells (￿9 in cultures: (a) without the inhibitor  of  protein  syn- 
thesis, cycloheximide;  (b) in which 10 #g/ml cycloheximide 
was added 2 h before  the addition of PMA and ionomycin, 
and was present throughout  the culture.  These  data  are based 
on four experiments. 
competes with M90 and M91 for binding to T cells expressing 
CD40L.  Tonsil T  cells  treated for  18  h  with  PMA  plus 
ionomycin were stained by indirect immunofluorescence with 
5c8, M90, and M91 alone and in the presence of dilutions 
of soluble recombinant CD40. Staining with M91 was com- 
pletely blocked by recombinant CD40 and staining with 5c8 
or M90 was blocked by more than 10-fold. These findings 
support the conclusion that most CD40L is inside T  cells 
in germinal centers, since the large amount of CD40 expressed 
by germinal center B cells would be likely to block the 5c8 
binding sites on CD40L expressed on the surface of germinal 
center T  cells (14). The level of CD40L expression detected 
by immunohistology was relatively weak and uniform. Iso- 
lated or clustered strongly positive cells were not seen, sug- 
gesting that high level expression induced by PMA and iono- 
mycin in vitro may not reflect physiological expression in vivo. 
Discussion 
Signaling through CD40 and CD40L interaction has been 
reported to be necessary for the initiation of T  cell-depen- 
dent Ab responses in mice (15).  During the early phase of 
responses to protein-based Ag, there seems to be a require- 
ment for T cells to interact sequentially with two cell types 
that have taken up and processed Ag. First,  they must in- 
teract with dendritic cells and, then, with B cells;  the first 
interaction priming the T  cells (reviewed in reference 30), 
and the second providing Ag-specific activation signals to the 
B cell.  It is unclear whether both of these specific interac- 
tions involve the transient expression of CD40L by the T 
cells at the site of cognate interaction. Both B cells and den- 
dritic cells constitutively express CD40 (14), suggesting that 
this might be the case. On the other hand, further signals 
delivered during specific T cell activation seem to act at one 
stage and not the other. Thus, when T cell-B cell signaling 
through  CD28/CTLA4  interaction  with  B7-1/B7-2 was 
blocked in vivo, T cell priming was unaffected, but the early 
stages of T  cell-dependent B cell activation were markedly 
impaired (31). Dendritic cells are markedly more efficient than 
activated B cells in priming virgin T  cells (32, 33), and evi- 
dence has been presented indicating that, under certain con- 
ditions, cognate interaction of virgin T cells with B cells in- 
Table 1.  Induction of Surface CD40L Expression by CD45RA-  CD8-  T  Cells with Anti-CD3-coated Ox RBC or PMA and 
Ionomycin, with and without Added Cycloheximide 
Experiment  1  Experiment  2  Experiment  3 
anti-CD3  PMA +  anti-CD3  PMA +  anti-CD3  PMA + 
ox RBC  ionomycin  ox RBC  ionomycin  ox RBC  ionomycin 
CX  CX  CX  cx  CX  CX 
O min  2  2  1  1  2  2  0  0  2  2  1  1 
15min  7  4  43  24  26  48  49  59  14  13  23  34 
1 h  18  17  43  7  38  57  nd  nd  20  23  25  28 
2 h  nd  nd  nd  nd  66  31  70  3  31  13  65  5 
4 h  29  8  89  7  47  14  98  5  17  7  82  2 
6 h  nd  nd  nd  nd  7  10  94  9  6  5  91  8 
20 h  10  1  95  7  1  3  48  2  0  0  63  0 
The values shown are the percent  cells expressing  CD40L at the time  intervals  indicated  after the addition of PMA and ionomycin  or CD3e mAb-coated 
ox KBC. The cultures represented in the columns headed cx had 10 #g/ml cycloheximide  added 2 h before the activation signals. The level of 
contamination of the CD45RA- CDS- T cells with CD45RA+ cells  was 10.2, 0.25, and 0.3% in experiments 1, 2, and 3, respectively,  and con- 
tamination with CD8 + cells was <1% in each experiment. 
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CD4  in Different Tonsil Compartments 
Outer  light 
T  cell  zone of 
marker  germinal  Remainder  of 
assessed  centers  light  zone  T  zone 
CD40L  4.4  •  1.8  0.6  •  0.2  2.0  _+  1.1 
CD45RO  7.0  _+  3.4  2.0  +  1.0  4.9  •  0.4 
CD4  7.3  +  3.6  2.0  •  1.1  13.5  •  4.0 
The results are expressed as the number of cells expressing  the molecule 
indicated per square millimeter _+ SD of 4-/~m-thick  tonsil section. Ob- 
servations  are based on the analysis of at least 250 cells in each area of 
three different tonsils.  The light zone is defined as that part of the ger- 
minal  centers  where Ki67+  cells are not confluent.  In this  study,  the 
limit of the outer light zone is defined by the band  of T  cells found in 
this compartment that occupies the part of the germinal center immedi- 
ately inside the foUicuhr mantle (see Fig. 4). A full description  of tonsil 
germinal  center  compartments  is given in reference  27. 
hibits the T  cells' activation  (33).  It will be interesting  to 
see if there is a difference in the ability of dendritic cells and 
B  cells  to induce  T  cells to  store preformed  CD40L. 
T cell priming is associated with a switch from predomi- 
nant  CD45RA  expression  to  the  expression  of CD45RO 
(24, 34-36).  It is unclear  from the present  study if this  is 
also accompanied by constitutive expression of intracellular 
CD40L,  as only 40%  of CD45RO + cells  in  the T  zones 
were found to contain CD40L. Kinetic studies of the acqui- 
sition of intracellular CD40L expression during T-dependent 
responses in vivo are required.  Induction  of the expression 
of surface CD40L by both the CD4 + CD45RA + and the 
CD4 § CD45RO + T  cell subsets has been described previ- 
ously (37).  The kinetics of induction of surface CD40L ex- 
pression by PMA and ionomydn in  these two T  cell sub- 
sets was reported to be similar,  but time points before three 
hours were not  studied.  In the experiments  reported here, 
major  differences  between  surface  CD40L  expression  by 
CD45RO + and CD45RA + cells were only seen in the first 
two hours after activation. These differences were made con- 
siderably more obvious when protein  synthesis was inhib- 
ited.  Different activation requirements  for CD45RO + and 
CD45RA + Th cells have been described by several authors 
(reviewed in reference 38).  Ag-specific activation  of CD4 + 
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Figure  4.  The location  of cells 
containing  CD40L  in  tonsil  sec- 
tions. CD40L staining, using mAb 
Mg0, is shown in the photomicro- 
graph a. Figs. b-d are further pho- 
tomicrographs  of the same area of 
serial sections  of the  same  tonsil 
stained, respectively, for expression 
of  Ki67 (b), CD45P,  O (c), and CD4 
(d). e identifies the areas in the serial 
tonsil  sections:  dark  zone  (DZ), 
light  zone  (LZ),  and  outer  zone 
(OZ) of a germinal center. The FM 
is the foUicuhr mantle surrounding 
the germinal centre,  and A is part 
of the follicular mantle of an adja- 
cent  follicle.  TZ  is  part  of a  T 
cell-rich zone, and CE is crypt epi- 
thelium. Note how the highest fre- 
quency of cells with CD40L in a is 
found  in  the outer zone and  the 
outer part of the T zone that abuts 
onto the follicular mantle, fshows 
the granular  nature of the CD40L 
staining.  (a-e)  xlO0, (1") x500. CD45RO +  T  cells  can be  produced by B  cells,  but  the 
CD45RA + CD4 + T cells seem to need the action of profes- 
sional APC (38, 39).  The phenotype of CD4 + CD45RA + 
and CD4 § CD45RO + T cells differ in the expression of the 
adhesion molecules CD11a,  CD29, CD2, and CD44 (these 
being at lower levels on the CD45P, A + T  cell subset [40, 
41]). Differences  in the expression  of these molecules may 
explain,  in part,  the different activation requirements  for 
both CD4 § T  cell subsets (42).  In addition, in memory T 
cell lines,  the TCR complex appears  to incorporate CD4 
and CD45  isoforms; these act  as three distinct entities in 
virgin cells, rendering them far less sensitive than memory 
cells to activation through their TCR (38,  43,  44). 
B cell activation in the T  zone results in the production 
of short-lived plasma cells (2) and B blasts  that migrate to 
follicles to form germinal centers (45, 46). Interference with 
CD40L expression, using Ab against CD40L in vivo, inhibits 
the formation of germinal centers  (16), although it is not 
clear if this inhibition is at the level of the T zone reaction, 
or germinal center formation, or both. Recirculating B cells 
(47) and newly produced virgin B cells (48) migrate into the 
outer parts of the T zone of the spleen and lymph nodes of 
rodents. The recirculating cells move on from there to the 
follicular mantles. The migration patterns of B cells into sec- 
ondary lymphoid tissues in humans is not known. Assuming 
this is similar to that in rats, their migration pathway would 
pass through the outer T zones in the tonsil where CD40b 
containing T  cells are concentrated. Ag-specific  migration 
of memory B cells from the marginal zone of the spleen to 
the outer T  zones has also been described (2). 
The speed at which T cells can express surface CD40L may 
be crucial  in germinal centers;  kinetic studies indicate that 
centrocytes either leave the light zone within 7 h or die by 
apoptosis in situ (2, 49).  The present study shows that cells 
with preformed CD40L that can express this rapidly on their 
surfaces are present in the outer zone of germinal centers. 
The presence  of CD4 § CD45RO § T  cells, both in the T 
zones of the tonsil and at the outer edge of germinal centers, 
has been noted previously (50). 
In the present studies,  it was found that when preformed 
CD40L was expressed on the cell surface, it was downregu- 
lated within 2 h  (Fig.  3 B). Yellin et al.  (51), in a recent 
report of a study of surface CD40L turn-over, indicate that 
interaction with CD40 induces rapid endocytosis of surface 
CD40L, thus limiting the length of surface expression of this 
molecule. Our failure to find constitutive surface expression 
of CD40L is consistent with the concept that this molecule 
is only expressed  in secondary lymphoid tissues at the site 
of cognate interaction. It seems important that bystander cells 
should not gain access to CD40L expressed by their neighbors 
if cells that acquire autoreactivity through hypermutation of 
their Ig V  region genes  are to be eradicated. 
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